GlassScriptPhysician profile
Lisa M Stubbs
NPI 1427222827
$3,190.61
in general payments reported to CMS, 2019-2025
43 companies · $781 in 2025
The $781 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $329 · 2022: $415 · 2023: $813 · 2024: $853 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,446.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,333.01 | 2021-2025 | |
| Tris Pharma INC | $221.21 | 2023-2025 | Dyanavel Xr |
| Novo Nordisk INC | $171.92 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $128.44 | 2021-2025 | Gardasil 9, Vaxneuvance, Proquad |
| Organon LLC | $111.80 | 2021-2025 | Nexplanon |
| Pfizer INC. | $81.80 | 2022-2025 | |
| Lilly USA, LLC | $81.32 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Astellas Pharma US INC | $76.23 | 2022-2024 | Veozah |
| Axsome Therapeutics, INC. | $71.85 | 2025 | Auvelity |
| Corcept Therapeutics | $64.90 | 2024-2025 | Korlym |
| Glaxosmithkline, LLC. | $64.55 | 2023-2024 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $54.80 | 2021-2024 | Spravato |
| Medtronic, INC. | $53.95 | 2023-2024 | Intellis Adaptivestim |
| Biohaven Pharmaceutical Holding Company LTD. | $47.53 | 2022 | |
| Boston Scientific Corporation | $47.47 | 2023-2025 | Wavewriter Alpha Prime 16 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Stubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.